Projekt
Bevacizumab, pemetrexed and cisplatin, or erlotinib and bevacizumab for advanced non-squamous NSCLC stratified by EGFR mutation status. A multicenter phase II trial including biopsy at progression (BIO-PRO trial)
Automatisch geschlossen · 2010 bis 2014
Früh Martin, Siano Marco
Keine Resultate gefunden.